FDA
-
In the midst of a market downturn, with a year-on-year sales increase of 50%, what did this biopharma do right?
A Biopharma with outstanding product innovation and internal adjustment capabilities has no reason not to navigate through the cycle
-
The fatal monkeypox outbreak is re-emerging, are the investigational drugs proven to be ineffective?
DrugTime team will follow up on this key subject. Please stay tuned
-
Celine Dion, the legendary pop diva, is waiting for a CAR-T therapy?
All our best wishes! We will continue to provide our assistance to drug discovery and development with full effort
-
19款FDA批准的基因疗法
根据2024年7月12日CBER主任Peter Marks博士的演讲和公开信息准备
-
秀发重回！FDA批准的「斑秃」新药，安全性怎么样？
2024年7月25日，印度第一大制药公司Sun Pharmaceutical 宣布FDA批准了Leqselvi（deuruxolitinib）一日两次8mg片剂用于治疗成人重度斑秃…
-
How to Maximize the Value of Innovative Drugs When Going Global? Former FDA and EMA Experts from Parexel Reveal the Best Plan
13 seasoned experts shared rather valuable information for 4 hours
-
Sarepta Therapeutics Announces Expanded US FDA Approval of ELEVIDYS to Duchenne Muscular Dystrophy Patients Ages 4 and Above
Congratulations to Sarepta Therapeutics and DMD patients!
-
Day One Announces Sale of Priority Review Voucher for $108 Million
Congratulations to Day One Biopharmaceuticals!
-
CAR-T Black Box Warning Controversy Again？
DrugTimes will follow this crucial matter and report timely
-
FDA的“圣诞节礼物”，印度裔杰青的首个FDA批准
《我和我的药时代》| 医药版《我和我的祖国》（诚聘歌手演唱） 印象中，每年的圣诞节前夕，美国食品药品监督管理局（FDA）都会多批准几款药物，作为送给药企和患者的“圣诞…
